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Abstract
Background: Bone fractures and loss represent significant costs for the public health system and often affect the
patients quality of life, therefore, understanding the molecular basis for bone regeneration is essential. Cytokines,
such as IL-6, IL-10 and TNFα, secreted by inflammatory cells at the lesion site, at the very beginning of the repair
process, act as chemotactic factors for mesenchymal stem cells, which proliferate and differentiate into osteoblasts
through the autocrine and paracrine action of bone morphogenetic proteins (BMPs), mainly BMP-2. Although it is
known that BMP-2 binds to ActRI/BMPR and activates the SMAD 1/5/8 downstream effectors, little is known about
the intracellular mechanisms participating in osteoblastic differentiation. We assessed differences in the
phosphorylation status of different cellular proteins upon BMP-2 osteogenic induction of isolated murine skin
mesenchymal stem cells using Triplex Stable Isotope Dimethyl Labeling coupled with LC/MS.
Results: From 150 μg of starting material, 2,264 proteins were identified and quantified at five different time points,
235 of which are differentially phosphorylated. Kinase motif analysis showed that several substrates display
phosphorylation sites for Casein Kinase, p38, CDK and JNK. Gene ontology analysis showed an increase in biological
processes related with signaling and differentiation at early time points after BMP2 induction. Moreover, proteins
involved in cytoskeleton rearrangement, Wnt and Ras pathways were found to be differentially phosphorylated
during all timepoints studied.
Conclusions: Taken together, these data, allow new insights on the intracellular substrates which are
phosphorylated early on during differentiation to BMP2-driven osteoblastic differentiation of skin-derived
mesenchymal stem cells.
Background
Fractures and bone loss impose high costs for the Public
Healthcare System. Furthermore, delayed-healing fractures
lead to recurrence lesion, with quality of life’s loss and in-
creased patient morbidity. In the normal healing process,
the bone tissue function is regenerated through endochon-
dral ossification and intramembranous ossification, which
often occur at same time at the lesion site, under the
influence of inflammatory agents, such as IL1, IL6 and
TNF-α [1,2], which induce migration and proliferation of
periosteum mesenchymal stem cells. These cells differenti-
ate into osteoblasts, the major step in the regenerative
process. However, during the individual’s lifetime, both the
availability and the ability of these cells to differentiate di-
minish, leading to incomplete or total absence of tissue re-
generation at the fracture site. Although physiological
details are well understood, the molecular aspects of the
differentiation process occurring in the osteoblast lineage
from adjacent mesenchymal cells remain unclear.
To address this issue, autologous Mesenchymal Stem
Cells (MSCs) have been utilized, improving the bone
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tissue regeneration capability and leading to reduction of
both total costs and hospitalization period, with a signifi-
cant decrease in lesion recurrence [3]. These cells gained
importance in Regenerative Medicine, due to their ability
to differentiate into chondrocytes, adipocytes and osteo-
blasts, and facility with which they may be isolated from
several organs, among which is the skin. Due to its func-
tion of protecting from exposure to deleterious agents,
such as UV light, physical injuries and pathogens, the
skin displays a high cell proliferation rate, which is
maintained by the self-renewal and differentiation cap-
abilities of the several stem cell populations present in
skin niches [4]. These cells are of particular interest,
since they may be easily isolated from the skin, in rea-
sonable amounts, being highly suitable for bone healing
and repair [5].
Although it is known that osteogenic differentiation in
MSCs is initiated through activation of canonical pathways
such as SMAD (Sma and Mothers Against Decapentaplegic)
proteins, the possible protein interactions with other path-
ways which may influence cell differentiation remain elu-
sive. The activation of different downstream signaling
cascade pathways, includes Hedgehog, Wnt, PTHr-P and
BMPs, which, in turn, activate the main transcription
factors related to osteogenesis through their respect-
ive pathways [1]. Smads, for example, may be positively
or negatively regulated by phosphorylation of different
residues, leading to activation or suppression of the BMP-
initiated signal [6]. These kinase pathways, in turn, acti-
vate downstream effectors in the cytoplasm and nucleus
by phosphorylating a network of substracts. Since the
study of protein phosphorylation depends mainly on
phosphospecific antibodies and the utilization of radioiso-
topes, identification of novel phosphorylation sites has
been a laborious task. However, the development of
mass spectrometry techniques by detection of inor-
ganic phosphate neutral loss through CID (collision in-
duced dissociation), originated from phosphoserine,
phosphotyrosine and phosphothreonine, has made it pos-
sible to describe these novel phosphorylation sites in sev-
eral proteins [7,8].
Even though the analysis of fragmented peptides using
MS tools is an alternative method, due to their negative
charge and low abundance, phosphorylated peptides
display poor ionization and are subjected to signal sup-
pression, when compared to the regular, non-modified
peptides [7,9]. Therefore, it is necessary to enrich for
the phosphorylated peptides population present in the
sample and to eliminate interfering ions. This may be
accomplished by using a metal affinity chromatography,
such as IMAC or TiO2, thus improving the detection
levels of modified peptides [8,10,11]. This technique,
coupled with stable isotope labeling of peptides for
quantitative proteomics, may provide information on
the proteins which are differentially phosphorylated dur-
ing BMP2-induced osteodifferentiation. An unexpensive
and practical method for quantitative proteomics is the
use of stable-isotope dimethyl labeling [12]. Primary
amine of tryptic peptides and the lysine ε-amino
group can react with formaldehyde in the presence of
cyanoborohydride through reductive amination, giving
rise to dimethylated amine as the product. Depending
on which stable isotope is used (13C or 2H), different
shifts in molecular mass may be achieved. Using both
non-modified formaldehyde and cyanoborohydride,
the mass shift is of 28 Da. Using both deuterated for-
maldehyde and cyanoborohydride, the mass shift is of
32 Da, and using 13C plus deuterated formaldehyde
and cyanoborohydride, the mass shift is of 36 Da. Each
isotope differs from each other by 4 Da per primary
amine labeled, with the comparison between different
samples being made by MS precursor ion identifica-
tion on extracted chromatograms [13].
Here, we employed mass spectrometry coupled to
TiO2 metal affinity chromatography techniques to un-
cover new players involved in mouse skin mesenchymal
cells (msMSCs) osteogenic differentiation.
Results
Quantitative phosphoproteome and proteome of msMSC
cells subjected to rhBMP2 osteoblastic differentiation
msMSC cells cultured in 100 mm dishes were treated
with rhBMP2 for different periods of time, in order to
assess protein phosphorylation changes during the
first steps of osteoblastic differentiation. Previous ex-
periments using the osteoblast differentiation medium
(ascorbic acid, beta-glycerolphosphate and dexametha-
sone) showed intense calcification of our murine skin MSCs
in 14 and 21 days (Forni et al., personal comunication).
Homogeneity of the skin dermal MSCs was probed through
a complete characterization of CD markers, namely:
CD31, CD90, CD34, CD73 and CD29 (Forni et al., unpub-
lished data), utilizing only cell populations displaying
greater than 90% purity for the osteogenic differentiation
assays.
Due to the use of three different isotopes to label the
samples and five different timepoints, it was necessary to
carry out two independent experiments, each of which
containing a light, an intermediate and a heavy isotope
(Figures 1 and 2). We also evaluated protein level
changes, through analysis of the total protein fraction
(TiO2 flow-through and washed peptides) in order to
compare total protein levels alterations. Since the TiO2
Flowthrough and Wash fractions represent more than
70% of the sample [14] and are highly complex, another
fractionation step was performed. HILIC separation was
used to reduce sample complexity, according to protein
hydrophilicity.
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Data analysis
The “raw” data acquired from Thermo LTQ-XL Orbitrap®
was converted to “.mgf” files and an in-house MASCOT
server was used to search for peptides containing dimethyl
and carbamylation as a fixed modification and for phos-
phorylation in serine, tyrosine and threonine. The Thermo
Proteome Discoverer software, version 1.1 was used to
quantify all peptides based on the total area of Extracted
Chromatogram (XIC), and the absolute values were nor-
malized using a LOWESS (locally weighted scatterplot
smoothing) algorithm (Figure 3). These data were input
into the StatQuant software to evaluate the overall protein
ratio by calculating the mean peptide ratio for all peptides
corresponding to a given protein. The list for all peptides
and phosphopeptides quantified can be accessed in the
Additional file 1, and a summary of upregulated and
downregulated phosphoproteins in each experiment,
sorted by period of time indutction with rhBMP2 is
shown in Additional file 2.
Phosphosite localization
To assign phosphorylation sites, normalized Mascot
delta score (nMD-score) was used [15]. Mascot delta
score is the difference between the top two scores for
the peptides identified by a given spectrum. Dividing this
value by the score of the top score (rank 1) peptide, nor-
malized delta score is obtained. In order to have 1% FLR
(False Localization Rate) for correct phosphosite assign-
ment with 99% certainty, peptides with nMD-score below
0.36 were discarded (corresponding to an MD-score of
10). A total of 950 unique phosphosites with 99% certainty
that the sites were assigned correctly (1% FLR) were iden-
tified. These sites were found on 235 different proteins
and their distributions were 87.5%, 11.5% and 0.8% for pS,
pT and pY, respectively, which is comparable to previous
works for mammalian cell types. All validated phospho-
sites with their MD-scores are listed in Additional file 1.
Phosphorylation motif database search
The analysis carried out to determine which kinase
could possibly be involved in phosphsorylation of a given
phosphorylated residue from phosphoproteome data was
performed using the NetworKIN site (http://networkin.
info/version_2_0/search.php). Figure 4 shows a summary
of the complete dataset (Additional file 3) represented
by a graph containing kinase motifs occurrencies.
Network analysis using the ingenuity pathway analysis
software
In order to evaluate possible intracellular interactors
with the phosphopeptides found, a network analysis was
Figure 1 Induction of cells and mass spectrometry experiment outline.
Figure 2 Stable Isotope Dimethyl labeling of tryptic peptides.
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Figure 3 Scatter plot analysis of labeled peptides. The plot compares the different stable isotope labeled peptides (represented as circles) as
follows: a) medium/light and b) heavy/medium. The 45º slope line shows a situation with no variation between the compared peptides, and circles that
do not match in this line represent the peptides that were found to be differentially abundant. A) regular peptides; B) phosphorylated peptides.
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performed. The Ingenuity Pathway Analysis software
(http://www.ingenuity.com/) was used to map relation-
ships among proteins, distributed into different cellular
compartments. From the total list of proteins found to
interact with phosphoproteins (Table 1 and Additional
files 4 and 5), hits containing a transcription factor func-
tion were selected for further analysis of DNA-binding
motifs in osteoblast differentiation-related genes. Non-
phosphorylated population of peptides were classified
according to biological process using the Gene Ontology
Blast2Go software (http://www.blast2go.com) in order to
map and annotate gene ontologies (Table 2).
Analysis of the promoter region of osteoblast-related
genes for the presence of responsive elements for the
BMP2-regulated transcription factors
After obtaining the list of transcription factors for the
Ingenuity® network analysis, a curated database for tran-
scription target genes, TRED was used to find target
genes and text mining was performed to find which tar-
get genes are related with osteoblastic differentiation.
We used the JASPAR database [16] which contains a cu-
rated, non-redundant set of profiles, derived from pub-
lished collections of experimentally defined transcription
factor binding sites for eukaryotes and sorted out the
transcription factor which have well defined binding
motifs (Figure 5) [17-19]. These motifs were used as a
template for a search in the promoter region of the pre-
selected genes, using the ENSEMBL cisRED database [20]
and those which displayed at least one match or multiple
matches for the sequences were selected for the qRT-PCR
analysis (Additional file 6). The consensus sequences of
sp1, c-Myc and NFkB were selected among others because
they were present in the promoter region in more them
80% of the selected genes for qPCR validation.
Analysis of differentially expressed genes involved in
osteoblastogenesis activated by BMP2-induced
transcription factors
We used analysis of regulatory networks in order to in-
vestigate which transcription factors were activated, and
which of them are related with activation of osteoblast-
related genes (Table 3). Thirteen genes were selected to
evaluate their role in osteoblastic differentiation of msMSC
cells, and to confirm the in silico analysis. From the initial
list of genes investigated, ten (TGF-beta receptor, TGF-
beta induced protein, Collagens 1and 4a1, Sox9, Smad2,
Twist and the osteoblast-specific genes RUNX2, OSX
and DLX5) were found to be upregulated at different
timepoints (Figure 6). The TGFB cytokine ant its receptor,
TGFBR1, displayed the regulated motifs in their promoter
regions. The mRNA relative levels of these two genes were
evaluated after 10 min, 30 min, 1 h and 2 h of exposure to
rhBMP2. The relative levels of TGFB1 were upregulated
more than two times after 30 min of rhBMP2 induction
(Figure 6A, 3.2 fold, p<0.001), but after reaching this peak,
Figure 4 Predicted kinase motifs of substrates found in mass spectrometry experiments.
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the relative levels decreased to basal levels after 2 h. This
pattern was followed by a subsequent increase in the
TGFBR1 mRNA relative levels of up to 3.6 fold at 1 h and
more than 4.9 fold at 2 h (Figure 6B, p<0.001). Since the
synthesis of extracellular matrix compounds, such as col-
lagens, is known to be regulated during osteo differenti-
ation, we selected two members of the collagen family
that displayed the selected motifs, namely: collagen 1 and
4a. Both ECM components were upregulated, with colla-
gen 1 displaying a punctual increase at 1 h after stimulus
(Figure 6C, 8.6 fold, p<0.001) and collagen 4a followed a
progressively rising pattern (Figure 6D, 5.96 fold at 1 h
and 10.8 at 2 h, p<0.05 and p<0.001, respectively). Related
to collagens and TGFB, the osteogenesis related gene
Twist presents a downregulation pattern (0.39 fold after
10 min) from the basal levels during the beginning of the
differentiation and after that a slight increase (1.6 fold) at
1 h, a decrease to 1.2 fold at 2 h (Figure 6E, p<0.05).
Expression of SMAD2 was accessed, in order to stabilish a
possible crosstalk between TGF-beta/Activin signaling
during BMP2-driven osteogenesis. The mRNA relative
levels of SMAD2 were accessed, presenting a slight in-
crease of 3.4 fold at 10 min and a major increase of more
than 7.5 fold at 2 h (Figure 6F, p<0.001).
We also evaluated a set of four transcription factors
which, in addition to presenting the regulated motifs in
their promoter regions, were key elements during the
osteoprogenitors differentiation. The relative mRNA
levels of RUNX2 were the first to be upregulated, in-
creasing almost 400 fold after 30 min, with a drastic des-
cent to levels similar to basal levels after 1 h (Figure 7A,
p<0.001). Another important transcription factor,
DLX-5, displayed a progressive increase at 10 min (14.4
fold, p<0.05) and 30 min (72.9 fold, p<0.001) reaching a
peak at 1 h (135.2 fold, p<0.001), followed by a sharp
decrease to basal levels at 2 h (Figure 7B). The transcrip-
tion factor Osterix displayed a stepwise increase, begin-
ning at 10 min, and reaching up to 10 fold after 2 h of
stimulation (Figure 7C, p<0.001). Similarly, the SOX9
mRNA level was upregulated at 30 min (6.4 fold, p<0.05)
and 1 h (15.2 fold, p<0.001) (Figure 7D).
Discussion
In the present study, we used murine skin mesenchymal
cells (msMSC) and stable dimethyl isotope labeling to
quantify abundant proteins and phosphoproteins using
TiO2 metal affinity chromatography, coupled with mass
spectrometry, at five different periods of rhBMP2 induc-
tion, namely: 0, 10, 30, 60 and 120 min. From 150 μg of
the combined samples, it was possible to identify and
quantify 235 distinct phophoproteins and 2,029 distinct
proteins, in all replicates. Based on the data acquired, and,
also, on references from the literature, we proposed a
model for BMP2-mediated osteodifferentiation differenti-
ation of these msMSCs cells. Previous experiments carried
out with these msMSCs, subjected to the osteoblast differ-
entiation medium (ascorbic acid, beta-glycerolphosphate
and dexamethasone) showed intense calcification at 14
and 21 days of treatment, with greater than 80% of the
cells being Alizarin Red-positive” (Forni et al., unpublished
data). This experiment could not be carried out solely with
BMPs-supplemented culture medium, due to its lack of
mineral components (e.g. beta-glycerolphosphate), which
is necessary for mineralization.
The data found showed to be compatible with bone
development, since BMPs act at the very early stages of
Table 1 Transcription factors predicted to interact with
phosphoproteins found in MS experiments
BARD1 BRCA1 associated RING domain 1
BMI1 BMI1 polycomb ring finger oncogene
CBX3 Chromobox homolog 3
CTNNB1 Catenin (cadherin-associated protein), beta 1, 88 kDa
HIC1 Hypermethylated in cancer 1
HMGA1 High mobility group AT-hook 1
HNF4A Hepatocyte nuclear factor 4, alpha
ID3 Inhibitor of DNA binding 3, dominant negative helix-loop-
helix protein
KDM5B Lysine (K)-specific demethylase 5B
MAZ MYC-associated zinc finger protein (purine-binding
transcription factor)
MTA1 Metastasis associated 1
MYC v-myc myelocytomatosis viral oncogene homolog (avian)
NFATC1 Nuclear factor of activated T-cells, cytoplasmic, calcineurin-
dependent 1
NFKB1 Nuclear factor of kappa light polypeptide gene enhancer
in B-cells 1
PPP1R13L Protein phosphatase 1, regulatory (inhibitor) subunit 13 like
SIAH2 Seven in absentia homolog 2 (Drosophila)
SMAD3 SMAD family member 3
SOX4 SRY (sex determining region Y)-box 4
SP1 Sp1 transcription factor
SREBF1 Sterol regulatory element binding transcription factor 1
TFDP1 Transcription factor Dp-1
TGFB1I1 Transforming growth factor beta 1 induced transcript 1
TLE1 Transducin-like enhancer of split 1 (E(sp1) homolog,
Drosophila)
YAP1 Yes-associated protein 1
CBX4 Chromobox homolog 4
E2F4 E2F transcription factor 4, p107/p130-binding
Predicted network of interaction for phosphoproteins found using Ingenuity
Pathway Analysis. The list of phosphoproteins found were subjected to
Ingenuity Pathway Analysis (IPA) to investigate problable protein interactions
for each cellular compartment. Proteins described to be transcription factors
were selected to investigate the activation of osteblast related genes by
quantitative real-time PCR.
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Table 2 Protein annotation for biological processes of upregulated proteins
10 min/0 h 30 min/10 min 1 h/30 min 2 h/1 h
GO term #Seq Score GO term #Seq Score GO term #Seq Score GO term #Seq Score
Signaling 14 4,21 Signaling 31 8,92 Signaling 40 13,3 Developmental process 47 15
Cellular response to
stimulus
19 5,67 Anatomical structure
development
22 9,48 Multicellular organismal
development
48 12,78 Signaling 17 4,13
Anatomical
structure
morphogenesis
13 4,21 Multicellular organismal
development
8 2,39 Anatomical structure
development
46 13,06 Anatomical structure development 41 12,3
Cell differentiation 18 5,95 Cell differentiation 6 2,48 Cell-cell signaling 9 2,96 Multicellular organismal development 43 8,57
Regulation of
signaling
6 1,08 Cell surface receptor linked
signaling pathway
3 2,6 Cell activation 7 3,18 Cell differentiation 20 9,36
Cell morphogenesis
involved in
differentiation
7 2,06 Cell morphogenesis involved
in differentiation
30 5,77 System development 40 10,12 Cell surface receptor linked signaling pathway 9 3,63
Organ development 21 8 G-protein coupled receptor
protein signaling pathway
4 3,2 Cell differentiation 33 15,09 Embryo development 7 3,14
Regulation of cell
differentiation
6 1,12 Signal transduction 8 2,14 Cytoskeleton organization 26 9,55 System development 36 8,95
Signal transduction 11 5,73 Epithelial cell differentiation 13 6,01 Regulation of signaling 20 6,75 Cell development 15 5,97
Phosphorylation 14 4,67 Cell surface receptor linked
signaling pathway
18 7,95 Cell morphogenesis involved in differentiation 9 2,47
Transmembrane receptor
protein tyrosine kinase
signaling pathway
4 2,56 Signal transduction 37 18,99 Organ development 26 10,7
Organ development 26 11,08 Regulation of signal transduction 6 2,1
Cell morphogenesis involved in
differentiation
13 3,15 Signal transduction 17 6,54
Enzyme linked receptor protein
signaling pathway
9 3,8 Epithelial cell differentiation 2 2
Intracellular protein kinase
cascade
7 3,34 Regulation of gene expression 14 4,89
G-protein coupled receptor
protein signaling pathway
6 4,77 Transmembrane receptor protein tyrosine kinase
signaling pathway
5 2,92
Small GTPase mediated signal
transduction
5 2,01 DNA damage response, signal transduction by
p53 class mediator resulting in cell cycle arrest
3 3
Second-messenger-mediated
signaling
3 1,22 Negative regulation of ubiquitin-protein ligase
activity involved in mitotic cell cycle
4 4
Wnt receptor signaling pathway 3 1,08 Positive regulation of ubiquitin-protein ligase
activity involved in mitotic cell cycle
4 4
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Table 2 Protein annotation for biological processes of upregulated proteins (Continued)
Phosphorylation 17 8,1 Regulation of ubiquitin-protein ligase activity
involved in mitotic cell cycle
4 4,8
Positive regulation of signal
transduction
9 5,2
Transmembrane receptor protein
tyrosine kinase signaling pathway
9 6,33
MAPKKK cascade 5 4
Negative regulation of cell
proliferation
5 4,6
Positive regulation of intracellular
protein kinase cascade
5 3
Negative regulation of cell cycle 4 1,84
Post-translational protein
modification
4 4
Ras protein signal transduction 4 1,68
Regulation of Wnt receptor
signaling pathway
3 1,56
Consistently upregulated proteins were input in Blast2go software for mapping and annotation of gene ontologies. Biological processes over-represented were selected and classified according to level. Top:
low levels; bottom.
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cells differentiation to the osteoblastic lineage, but, later
on in the process, these cells incorporate mineral precur-
sors and originate the calcified bone tissue. The kinases
which showed the highest number of phosphorylation
motifs in phosphodata were represented, as well as gene
activation for each time period studied (Figure 8).
We used triplex stable isotope dimethyl labeling to com-
pare five different time periods of rhBMP2-induced osteo-
blastic differentiation of skin mesenchymal cells, combined
into two different experimental groups (an “early period”
group, which comprised the 0 h, 10 min and 30 min sam-
ples and a second, “late period” group, comprised of the
30 min, 1 h and 2 h samples). This was necessary in order
to correctly compare the phosphoprotein ratios with their
respective protein levels, since we do not expect a wide
protein level variation during the period studied and, also,
to avoid aberrations in phosphoprotein variation. Similarly,
Song and colleagues [21] used similar approach through a
pseudo-triplex dimethyl labeling in liver tissue samples and
hepatocellular carcinoma.
Each pooled sample was split according to the affinity
of peptides for the TiO2 column. The TiO2-Flowthrough
fraction was subjected to HILIC and fractionated. Since
this step decreased the sample complexity, it enhanced
the number of peptides which could be identified and
quantified, when compared to the entire pool, which
was directly injected into the LC/MS (data not shown).
Since we started from a relatively low amount of sample
(50 μg of protein extract for each timepoint and 150 μg
for a triplex experiment), no improvement in the num-
ber of detected peptides was obtained using HILIC in
phospho-enriched samples. Analysis of the data also
showed that there is a tendency for many phosphopeptides
to be upregulated between 30 min and 1 h of rhBMP2
treatment, correlating with the period of activation for the
Dlx5 transcription factors which trigger the expression of
Table 3 List of Primers used in qRT-PCR
Gene 5′- 3′ nucleotide sequence
mBMP-2 F TCTTCCGGGAACAGATACAGG
mBMP-2 R TGGTGTCCAATAGTCTGGTCA
mOsterix F ATGGCGTCCTCTCTGCTTG
mOsterix R TGAAAGGTCAGCGTATGGCTT
mRunX-2 F GACTGTGGTTACCGTCATGGC
mRunX-2 R ACTTGGTTTTTCATAACAGCGGA
mDlx5 F CACCACCCGTCTCAGGAATC
mDlx5 R GCTTTGCCATAAGAAGCAGAGG
mTGFb1 F CTCCCGTGGCTTCTAGTGC
mTGFb1 R GCCTTAGTTTGGACAGGATCTG
mSMAD-2 F ATGTCGTCCATCTTGCCATTC
mSMAD-2 R AACCGTCCTGTTTTCTTTAGCTT
mTGFbR2 F CCGCTGCATATCGTCCTGTG
mTGFbR2 R AGTGGATGGATGGTCCTATTACA
mTwist1 F GGACAAGCTGAGCAAGATTCA
mTwist1 R CGGAGAAGGCGTAGCTGAG
mSox9 F GAGCCGGATCTGAAGAGGGA
mSox9 R GCTTGACGTGTGGCTTGTTC
mCol4a1 F CTGGCACAAAAGGGACGAG
mCol4a1 R ACGTGGCCGAGAATTTCACC
mCol-1 F GCTCCTCTTAGGGGCCACT
mCol-1 R ATTGGGGACCCTTAGGCCAT
mCol-2 F CAGGATGCCCGAAAATTAGGG
mCol-2 R ACCACGATCACCTCTGGGT
List of primers used to amplify the cDNA in order to investigate changes in
mRNA upon BMP2 treatment in qRT-PCR. F: forward; R: reverse.
Figure 5 Transcription factor motifs found for selected osteodifferentiation genes.
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RUNX2 and OSX, both of which are upregulated upon
rhBMP2 administration [22,23].
In order to compare measurements across LC-MS/MS
experiments and to correct for non-biological variation
(such as the bias generated in the sample quantification),
data normalization is a crucial step prior to any further
analysis. The standard normalization assumed in LC/MS
experiments is based on dividing all peptide ratio values
by log2. However, notice that this procedure only divides
the peptide abundance by a common factor, re-scaling
the relative abundance of the peptide. In other words, this
“within sample” normalization does not remove the bias
in the quantities across experiments. In order to remove
the systematic errors introduced in different experiments,
Figure 6 mRNA fold change measured by qRT-PCR for osteoblast related genes. Quantitative Real Time PCR of osteoblast related genes
from rhBMP2 induced sMSC at indicated timepoints were normalized and compared according to housekeeping genes as control: mHPRT -
hypoxanthine phosphoribosyltransferase 1, mGAPDH - glyceraldehyde-3-phosphate synthase and mHMBS - mouse hydroxymethylbilane synthase.
A) TGFB1 relative levels were upregulated 3.2 fold after 30 min of rhBMP2 induction (p<0.001) followed by a decrease to basal levels after 2 h.
B) TGFBR1 mRNA increase levels of up to 3.6 fold at 1 h and more than 4.9 fold at 2 h (Figure 6B, p<0.001). C) COL1 displays a punctual increase
at 1 h after stimulus (8.6 fold, p<0.001). D) COL4A showed a progressively rising pattern at timepoints studied (5.96 fold at 1 h and 10.8 at 2 h,
p<0.05 and p<0.001, respectively). E) TWIST is downregulated (0.39 fold after 10 min) but after 1h shows a slight increase (1.6 fold) at 1 h.
F) SMAD2 presented a slight increase of 3.4 fold at 10 min and 2 h (p<0.001). Data represent three independent experiments and standard
deviation bar is shown for all experimental timepoints studied. Asterisks represents levels of significance for statistical analysis (Two-Way ANOVA,
Bonferroni test) between control and treatment groups (*p<0,05 and **p<0,01). ns: non statistically significant.
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we applied the LOWESS regression, a technique com-
monly applied to microarray data analysis [24]. One prem-
ise to apply LOWESS normalization is that the differences
among the overall intensity of different experiments would
be the consequence of non-biological variation, i.e., most
peptides will not show a significant change in the abun-
dance between the two compared samples (peptides
derived from closely related samples). Briefly, in a
well performed experiment, the scatter-plot of pep-
tides of one sample versus another would cluster the
peptides along a straight line, and the slope would be
equal to 1. Normalization of these data is equivalent to
calculating the best-fit slope using regression techniques
and adjusting the intensities so that the calculated slope
is 1. However, sometimes, the intensities may be non-
linear, therefore, local regression techniques, such as
LOWESS regression, are more suitable. LOWESS regres-
sion [25] is estimated through a locally weighted polynomial
regression for a subset of peptides in the neighborhood
of each peptide. For more details, please refer to [26].
BMP2 induces phosphorylation of substrates for different
kinases in msMSCs
Kinase prediction analysis using the NetworKIN data-
base, from the phosphorylated peptides found, suggested
that, three major kinases could be acting as effectors of
phosphorylation upon BMP2 treatment, namely: Casein
kinase II (CK2), p38 MAPK and JNK. These kinases are
followed, to a lesser extent, by Activin receptors and the
CDK family of kinases. These data are in agreement with
the literature of the field, since Bragdon and colleagues
[27,28] showed the involvement of CK2 in BMP2-
induced cells. The release of CK2 from BMP receptor
type I (BMPRI) is related with osteblastogenesis, since
specific peptides which interfere with this interaction,
destabilize the CK2-BMPRI complex and enhance osteo-
blastic differentiation. It is possible that the role of CK2 in
osteogenesis is much more than its release from BMPRI,
involving many of the substrates found in this work and
even other ones which could contribute to the enrollment
of these undifferentiated stem cells to osteoblastogenesis.
The involvement of p38 MAPK in BMP2-driven
osteoblatogenesis is well-known. Several studies [1,23]
show activation of p38 within the first hour of BMP2 in-
duction, and activation of Dlx5 and Osx, essential genes
involved in osteblastic differentiation [23], as well as al-
kaline phosphatase. We confirmed these data in our
model using quantitative real-time PCR experiments,
showing an increase in mRNA relative expression for
Osx and Dlx5. It is interesting to note that p38 may be
Figure 7 mRNA fold change measured by qRT-PCR for osteoblast related genes (continued). A) RUNX2 showed an intense upregulation,
increasing almost 400 fold after 30 min, with a drastic descent to levels similar to basal levels after 1 h (p<0.001). B) DLX-5, displayed an increase
at 10 min and at 30 min (14.4 fold, p<0.05, 72.9 fold, p<0.001, respectively) reaching a peak at 1 h (135.2 fold, p<0.001), followed by a decrease to
basal levels at 2 h. C) OSX showed an increase, from 10 min to 2 h after stimulation (p<0.001). D) SOX9 was upregulated at 30 min (6.4 fold,
p<0.05) and 1 h (15.2 fold, p<0.001). Data represent three independent experiments and standard deviation bar is shown for all experimental
timepoints studied. Asterisks represents levels of significance for statistical analysis (Two-Way ANOVA, Bonferroni test) between control and
treatment groups (*p<0,05 and **p<0,01). ns: non statistically significant.
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involved in phosphorylation of several phosphoproteins
found in our study, since 120 sites were predicted to be
phosphorylated by this kinase.
Upon BMP2 treatment, JNK may also be activated, as
previous studies described [29-32]. We found that 9% of
all sites could be phosphorylated by this kinase up to 2 h
of BMP2 treatment. Interestingly, JNK is transiently acti-
vated in MC3T3-E1cells, in a short window (from 2 h to
4 h after BMP2 induction), stimulating the expression of
osteocalcin. However, at late periods of BMP2 induction,
JNK acts inhibiting the RUNX2 function by its phos-
phorylation at Ser 104 in C2C12 cells [30]. These results
show the dual function of JNK in osteoblastogenesis,
which is regulated in a time-dependent manner. At early
periods of time, JNK may have a role inducing osteogenesis,
by phosphorylating intracellular substrates and augmenting
the cellular sensibility for BMP2 [31]. On the other hand, at
late periods, JNK would participate by slowing down the
intracellular signaling for osteodiffentiation.
Similar number of phosphorylated sites were found
for the CDK group of kinases. These kinases are re-
lated with cell cycle progression, and their activation
or inhibition is associated with proliferation and quies-
cence, respectively. At a first glance, the activity of CDK
kinases could lead to an impairment of osteoblastic differ-
entiation, due to stimulation of cell proliferation. The role
of CDK in osteoblastic differentiation is not well under-
stood yet, however, its inhibitor, the p21 protein, has
been involved in osteoblastic differentiation since p21
null mice exhibit enhanced osteoblastic differentiation,
and overexpression of p21 protein delays bone forma-
tion [33]. It is possible that p21 could act independently of
CDK, activating or repressing genes in the nucleus, with its
role controlling osteoblastic differentiation being more
complex than simply regulating the cell cycle. Further stud-
ies will be required to address this issue and how CDK/p21
regulation participates in osteoblastic differentiation.
Biological processes overrepresented in BMP2-treated
msMSCs
The proteomic data obtained were analyzed using the
Gene Ontology classification. We observed which gene
ontologies could be representative of the upregulated
genes. Surprisingly, we found a high number of ontologies
Figure 8 Proposed model for BMP2-mediated osteoblast differentiation in msMSCs.
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containing the following terms: multicellular organismal
and anatomical structure development (48 and 46 entries,
score 12.78, and 13.06 respectively), signal transduction
(37 entries, score 18.99) signaling (40 entries, score 13.3),
cell differentiation (33 entries, score 13.06), cell surface re-
ceptor linked signaling pathway (18 entries, score 7.95)
and phosphorylation (17 entries, score 8.1) at the first
hour of BMP2 treatment, in contrast with the first 10 and
30 min periods of induction, which showed a few gene on-
tologies with these terms assigned. This can be due to the
fact that short periods of time are not sufficient to change
the overall amount of protein in the cell [34], therefore,
transcription and translation of new proteins must take
place before we can observe changes in protein levels,
which are sufficient to affect the gene ontologies classifica-
tion observed. Nevertheless, comparing the second hour
of BMP2 induction with the first one, less gene ontologies
could be classified, leading to the conclusion that these
proteins involved with signaling are regulated within the
first hour BMP2 induction.
BMP2-treated msMSCs phosphorylate intracellular
messengers which, in turn, activate osteoblastic-related
genes
BMP2 induction was shown to modify the post-
translational modifications of intracelular proteins, at
the timepoints studied. In order to investigate how these
phosphorylated proteins activate transcription factors,
and whether they are related with the activation of
osteoblastic genes, a network analysis of proteins found
in the phosphoproteome of BMP2-treated msMSCs was
carried out. Through Ingenuity network analysis, we
found different transcription factors related with the
phospho data. However, not all of the transcription fac-
tors found were described to have any participation in
osteoblast differentiation, or activation of osteoblastic re-
lated genes. Using a curated database for transcription
target genes, TRED, a transcription factors binding mo-
tifs occurrence, JASPAR, and the literature on the field
to search for osteoblastic target genes, one by one, we
found three transcription factors from the Ingenuity out-
put list, displaying important roles in osteoblastogenesis,
namely: SP1, c-Myc e NF-ƙB.
TGF-β/BMPs are widely recognized for their role in bone
formation during mammalian development, exhibiting ver-
satile regulatory functions in the body [35]. In accordance
with this finding, we observed increased levels of the
mRNA for both the TGFB cytokine and for its receptor
TGFBR. Also, signaling transduction by TGF-β/BMPs oc-
curs specifically through both canonical Smad-dependent
pathways (TGF-β/BMP ligands, receptors and Smads) and
a non-canonical Smad-independent signaling pathway
(e.g. p38 mitogen-activated protein kinase pathway,
MAPK). Following TGF-β/BMP induction, both the Smad
and p38 MAPK pathways converge at the RUNX2 gene to
control mesenchymal precursor cell differentiation, which
has also been found to have increased mRNA levels.
SOX9, a transcription factor of the sex-determining re-
gion Y (SRY)-related high mobility group box family of
proteins, is crucial for skeletal development and marks
all osteoblastic progenitors [36], being capable of indu-
cing RUNX2 expression [37-39] . However, the role of
SOX9 in osteoblastic differentiation is not completely
understood. Conditional deletion of SOX9 in the limb bud
mesenchyme led to the absence of chondrocytes and osteo-
blasts [40]. Contrastingly, when SOX9 was deleted in the
neural crest cells that contribute to the craniofacial skel-
eton, the cells which normally form chondrocytes expressed
osteoblasts markers [41], suggesting the existence of a the
bipotential progenitor. However, SOX9 is not expressed by
mature osteoblasts [36] and this is the probable cause of its
downregulation after 2 h of the stimulus.
COL1 and COL4A display functions related with the
building of the basal membrane for the newly-formed
mature bone tissue. A recent report of comparative
transcription of various fetal and adult mesenchymal
stem cells sources through quantitative PCR profiling un-
veiled that collagens, such as collagen 1 and 4, were
upregulated during several types of osteogenic differenti-
ation, such as the one reported in this manuscript with
the levels of these two extracellular matrix components
being increased [42]. Supporting these findings, it has
been reported that site mutations in collagen 1 leads to
high bone mass in osteogenesis imperfecta [43].
Since the bHLH transcription factor Twist inhibits
osteoblast differentiation through binding to a DNA-
binding domain in RUNX2 [44], the early downregulation
of this gene to levels below the basal level at 10 and
30 min could be indicative that the differentiation process
was mediated by RUNX2. Moreover, it has been shown
that RUNX2, a Runt domain-containing transcription fac-
tor, is indispensable for osteoblastic differentiation during
both endochondral and intramembranous ossification and
the function of mature osteoblasts, including the synthesis
of bone matrix. Homozygous deletion of Runx2 in mice
resulted in a complete lack of osteoblasts [41]. Our results
show a sustained increase in the mRNA levels of this tran-
scription factor after 30 min, pointining to the involve-
ment of this gene in the osteogenesis induced by exposure
to BMP2. Another essential gene related with osteoblastic
differentiation is OSX, a transcription factor containing
three zinc-fingers [45]. OSX was discovered as a BMP-
induced gene in C2C12 cells, with its deletion resulting
in complete absence of osteoblasts in mouse embryos,
despite the relatively normal expression of RUNX2 [39],
which indicates that OSX is activated after RUNX2 during
osteoblastic differentiation. In accordance, we observed
that after a significant increase in RUNX2 after 30 min of
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induction, a consistent increase of mRNA OSX levels is ob-
served up to 2 h after stimulus. Finally, we analized the ex-
pression levels of DLX-5, an homeobox gene that plays an
essential role in craniofacial, axial, and appendicular skeletal
development [46], and specifically regulates RUNX2 ex-
pression by binding to the homeodomain-response ele-
ments in the RUNX2 distal promoter [47]. The increased
amounts of DLX-5 after exposure to BMP2 indicates that
this gene is also present in our differentiation event, gener-
ating a reliable axis between DLX-5/RUNX-2/OSX.
Novel phosphorylated candidates found upon BMP2
treatment of msMSCs
From all three independent experiments, we chose pro-
teins which displayed increased phosphorylation upon
BMP2 treatment: a group of proteins related with cyto-
skeletal rearrangement and Ras protein signal transduction.
Cytoskeletal rearrangement is observed during osteoblastic
differentiation through the shift from a fibroblast-like to a
spheric phenotype, upon induction with supplemented
osteogenic differentiation medium (ODM), being antago-
nized by treatment with cytochalasin D, leading to a re-
duction of differentiation markers expression [48]. Thus,
catenin alpha 1, alpha parvin, septin-2, caldesmon, micro-
tubule associated proteins 1B and 4, nexilin, cytoplasmic
dynein 1 light intermediate chain and isoforms of lamin
A/C and plectin 1 were found to be upregulated at all time
periods studied. Together with the previous studies which
had described activation of these proteins using ODM
[48,49], we found that these proteins were also activated
upon BMP2 treatment. This may be explained by the fact
that a common subset of proteins can be activated by both
BMP2 and components of ODM, phosphorylating other
proteins related which cytoskeletal rearrangement. An-
other protein related with cytoskeletal rearrangement
found in our experiments was Rho GTPase-activating pro-
tein. The Rho family of GTPases plays an important role
in osteoblastic differentiation, shown by differentiation to
osteogenesis of constitutively RhoA-expressing mesenchy-
mal stem cells [50]. Other proteins involving signaling
pathways in osteoblastic differentiation were positively
phosphorylated, namely: Transforming growth factor beta
1 induced transcript (Hic-5) and Bcl-2-associated tran-
scription factor 1 displayed increasing phosphorylation
levels. These proteins are related to the Wnt pathway and,
specifically, Hic-5 was involved in regulation of intracellu-
lar signals by Smad 1, 5 and 8, effector proteins of the ca-
nonical BMP2 signaling pathway [51].
Conclusions
Stable isotope dimethyl labeling of peptides may be used
to quantify small amounts of proteins phosphorylated in
cell extracts. During BMP2-induced differentiation in
skin derived mesenchymal stem cells, it was possible to
acess different proteins, which many of them were found
to be phosphorylated in different timepoints, giving new
cues about the events that occur in the short term of
osteoblastic differentiation.
Methods
Cell isolation
The cells were isolated from BALB/C mice dermis
through careful dissecation from skin and FACS sorting,
being CD105+, CD73+, CD90+, lacking CD14 and CD34
as surface markers (more than 90% purity), being able to
growth under plastic and differentiate into osteoblastic
cells by osteodifferentiation-induced assay (ascorbic acid,
beta-glycerolphosphate and dexamethasone) and Alizarin-
Red stainig after 14 and 21 days. These cells were also cap-
able of chondro, osteo and adipogenesis, validated through
histochemistry and gene expression assays (Forni et al., in
preparation), as described in the literature [52].
Materials
The protease (Benzonase®) and phosphatase inhibitor cock-
tail (Complete®), were purchased from Roche (Mannheim,
Germany). Modified porcine trypsin was purchased
from Promega (Fitchburg, USA). DTT, ammonium bi-
carbonate, sodium cyanoborohydride, iodoacetamide,
triethylammonium bicarbonate (TEAB) and glycolic
acid, were from Sigma (Steinheim, Germany). CD2O
(98% D, 20 wt%),13CD2O (99%
13C, 98% D, 20 wt%),
and sodium cyanoborodeuteride (96% D) were from
Isotec (Miamisburg, USA). Formaldehyde (37%) and
ammonia solution (25%) was purchased from Merck
(Darmstadt, Germany). Poros Oligo R3 reversed-phase
material was from PerSeptive Biosystems (Framingham,
USA). TiO2 beads were obtained from GL Science (Tokyo,
Japan). EmporeTM C8 extraction disk was from 3 M
Bioanalytical Technologies (St Paul, USA). The water used
in all experiments was obtained from a Milli-Q purification
system (Millipore, USA). All other chemicals were pur-
chased from commercial sources and were of analysis
grade.
Total protein extract from murine-derived mesenchymal
stem cells induced with rhBMP2
Cell extracts from mesenchymal stem cells were made
as previously described [53], with some modifications.
Briefly, murine skin-derived mesenchymal stem cells
(msMSC) obtained in our laboratory, were seeded
onto 100 mm diameter culture plate in Dulbecco’s
modified Eagle’s Medium (DMEM) containing Glutamax-
I (Life Technologies, USA), 1% penicillin/streptomycin
(Life Technologies, USA) and 10% fetal bovine serum (Life
Technologies, USA) at 37°C until they reached 90% con-
fluence. The medium was then changed in each experi-
mental group (10 min, 30 min, 1 h and 2 h) for DMEM
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supplemented with 200 ng/ml of rhBMP2 (Life Technolo-
gies, USA) and 10% fetal bovine serum. After the induc-
tion period, the cultures were washed twice with ice-cold
PBS buffer. After washing, cells were harvested and the
cell suspension was then centrifuged at 1,000 g for 5 min.
The cell pellet was ressuspended in 100 μl of lysis buffer
(7 M urea (Sigma, Steinheim, Germany), 2 M thiourea
(Merck), 1% N-octyl glycoside (Sigma, Steinheim, Germany),
40 mM Tris (Sigma, Steinheim, Germany) containing
phosphatase and proteinase inhibitors (PhosStop and
Complete – Roche) and 300 units of Benzonase (Merck).
The cells were then sonicated at 40% output with intervals
of 3 × 15 s on ice to disrupt the cells and then incubated
at −80°C for 30 min. After incubation, 20 mM DTT was
added, and samples were incubated at room temperature
for 35 min. Iodoacetamide (40 mM) was then added,
followed by incubation for 35 min at room temperature in
the dark. For protein precipitation, 14 ml of ice-cold acet-
one was added to the solution, followed by incubation
at −20°C for 20 min. The proteins were pelleted by
centrifugation at 6,000 g for 10 min at 4°C, and the
pellet was stored at −20°C until further use. The BCA
method was used to determine the protein concentra-
tion of each sample.
Tryptic digestion of total protein extracts
Precipitated proteins from msMSC cells were solubilized
in 100 mM TEAB, and 50 μg of total protein extract,
quantified by the bicinchoninic acid assay kit (Pierce,
Waltham, USA), incubated with chemically modified
trypsin at a proportion of 1:100, and subsequently incu-
bated at room temperature for 18 h.
R3 microcolumns for desalting
The Poros Oligo R3 reversed phase resin was suspended
in 70% acetonitrile. The R3 beads were loaded onto
constricted GELoader (Eppendorf, Hamburg, Germany)
tips containing a C8 microdisc and gentle air pressure
was applied to pack the beads in order to obtain R3
microcolumns of 3 mm [54]. Each acidified sample was
loaded onto an R3 microcolumn. The R3 microcolumns
were subsequently washed with 30 μl of 0.1% TFA,
and the peptides were eluted from the Poros R3 col-
umn using 30 μl of 70% acetonitrile, 0.1% TFA. The
phosphopeptides were subsequently ressuspended in
0.5 μl of 100% formic acid and 10 μl of (0.1% formic
acid) prior to nanoLC-MS analysis.
Dimethyl labeling
After digestion, the total protein extract was quantified
by the BCA method and the volume was adjusted to
100 μl of 100 mM TEAB. CH2O (4 μl, 4%, “light”) or 4%
CD2O (“intermediate”) or 4%
13CD2O (“heavy”) was added,
followed by the addition of 4 μl of 600 mM NaBH3CN
(light and intermediate) or 4 μl of 600 mM NaBD3CN
(heavy). The mixture was incubated for 1 h at room
temperature. The reaction was quenched with 16 μl of 1%
ammonia and 8 μl formic acid was added. The differen-
tially labeled samples from three different time points were
pooled and desalted using microcolumns filled with Poros
R3 beads. This sample was subjected to vacuum centrifu-
gation and stored at −20°C for further use.
Titanium dioxide (TiO2) chromatography
The pooled samples were subjected to the phosphoenrichement
procedure by mixing with TiO2 beads, which were
ressuspended in loading buffer (1 M glycolic acid in 80%
acetonitrile, 5% TFA). 15 mg of TiO2 beads (suspended in
100% acetonitrile) were washed in loading buffer and
loaded into the sample tube. The mixture was incubated
for 15 min at ambient temperature under agitation
(150 rpm). The mixture was centrifuged for 60 s at
12,000 g and the supernatant was collected, dessalted,
and lyophilized. The TiO2 beads, complexed with
phosphopeptides, were washed twice with 500 μl of
loading buffer and, subsequently, with 30 μl of washing
buffer (80% acetonitrile, 5% TFA). The phosphopeptides
were eluted using 50 μl of ammonium water (pH 11.3)
followed by 10 μl of 30% acetonitrile. The eluent was acid-
ified by adding 5 μl of 100% formic acid prior to the
dessalting step.
Offline TSK amide-80 HILIC peptide fractionation
Peptide fractionation was performed using a neutral TSK
Amide-80 HILIC (3 μm; Tosoh Bioscience, San Francisco,
USA) and a mobile phase containing TFA. The purified
peptides were ressuspended in 90% acetonitrile, 0.1% TFA
and loaded onto a 320 μm inner/450 μm outer diameter ×
17 cm microcapillary column packed with TSK Amide-80
using an Agilent 1200 Series HPLC (Agilent, Santa Clara,
USA). The HPLC gradient was 100-60% of solvent 90%
acetonitrile/0.1% TFA in water for 42 min at a flow-rate of
6 μL/min. Fractions were collected every minute and com-
bined into 8–12 fractions depending on the intensity of UV
detection measured at 210.8 nm. The fractions were dried
by vacuum centrifugation.
Nano-LC-MS
Nano-LC-MS experiments were performed using a 7-tesla
LTQ-FT mass spectrometer (Thermo Electron, Bremen,
Germany). The sample was applied onto an EASY nano-
LC system (Proxeon Biosystems, Odense, Denmark). The
peptides were loaded onto an 18 cm analytical column
(100 μm inner diameter/360 μm outer diameter, ReproSil-
Pur C18 AQ 3 μm (Dr. Maisch, Ammerbuch-Entringen,
Germany), and eluted from the column using a gradient
from 100% phase A (0.5% acetic acid aqueous solution) to
40% phase B (0.5% acetic acid, 80% acetonitrile) in 113 min
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at 45 nl/min. The instrument was operated in a data-
dependent mode automatically switching between MS,
MS2, and pdMS3 [55]. The top 10 parent ions of the spectra
were chosen for fragmentation. The pdMS3 acquisition was
set to automatically select and further fragment the frag-
ment ion originating from the loss of phosphoric acid from
the parent ions (standard pdMS3 settings).
Database analysis
The “.raw” MS data were processed using the
ThermoProteome Discoverer software (Thermo Elec-
tron, Bremen, Germany). The generated “.mgf” files were
subsequently searched against the murine sequence li-
brary in the International Protein Index (IPI) protein se-
quence database (IPI mouse v3.77) using an in-house
Mascot server (version 2.1) (Matrix Science Ltd. London,
UK). The search was performed by choosing trypsin as the
enzyme with two miss-cleavages allowed. Carbamidomethyl
(Cys), dimethyl labeling for light, medium and heavy modi-
fications of N-terminus and Lys (+28,+32 and +36 Da, re-
spectively) were chosen as the fixed modification. As
variable modifications, oxidations (Met) and phosphoryl-
ation (Serine, Threonine and Tyrosine, S,T,Y), were chosen.
The data were searched with a peptide mass tolerance of
10 ppm and a fragment mass tolerance of 0.8 Da. A
concatenated decoy database search was performed in a
concatenated decoy mouse database (IPImousedecoy) de-
rived from the IPI mouse database listed above for each of
the conditions, and only peptides with up to 1% of False
Discovery (FDR) were selected. Dimethyl quantification
was performed using Thermo Proteome Discoverer (v1.1)
from the extracted chromatograms (XIC’s) obtained.
Normalization was achieved using the LOWESS fitting al-
gorithm [24] and protein grouping and statistics were
obtained using StatQuant [56]. The phosphopeptide
subpopulation were compared to a databasis
consisting of motifs for phosphorylation by different
kinases in NetworKIN website (http://www.networkin.
info/version_2_0/) [57]. Non-phosphorylated popula-
tion of peptides were classified according to biological
process using the Gene Ontology software Blast2go
[58] (http://www.blast2go.com). Ingenuity (Ingenuity
Systems, Redwood City, USA) was used to investigate
protein network interactions. TRED (http://rulai.cshl.
edu/cgiin/TRED/tred.cgi/process=home) was used to
search for gene targets for transcription factors and
JASPAR (http://129.177.120.189/cgibin/jaspar2010/
jaspar_db.pl) was used to check for transcription fac-
tor binding motifs.
Total mRNA extraction and purification from
rhBMP2-induced msMSC cells
3.104/ cells per ml were seeded onto 100 mm diameter cul-
ture plate. After treatment with rhBMP2 (Life Technologies,
USA) for different time periods, cells were washed with
ice-cold PBSA, and total mRNA was isolated using silica
columns from the RNeasy® mini-kit (Qiagen, Hilden,
Germany). The mRNA concentration was determined by
absorbance at 260 nm and the purity of the preparations
was evaluated by the A260nm/A280nm ratio, with purity
being considered when this ratio was approximately 2.0.
cDNA synthesis
Total cellular RNA, isolated as mentioned above, was
used to synthetize the corresponding cDNA. An aliquot
(1 μg) of RNA from each condition was incubated with
2 units of DNase I (Thermo Fischer Scientific, Waltham,
USA) and 20 units of RNAseOUT for 10 min at 37°C.
After this incubation period, both enzymes were heat-
inactivated for 10 min at 75°C and 1 μl of 0.5 μg/μl of
oligo-dT, 1 μl of 10 mM dNTP, were added. The samples
were incubated for 10 min at 65°C and then immediately
placed on ice. After addition of 200 units of SuperScript®,
2 μl of 100 mM DTT and 20 units of RNAseOUT were
added to each tube, samples were incubated for
10 min at 25°C for primer annealing, and then for
120 min at 50°C for cDNA synthesis. SuperScript® en-
zyme was heat-inactivated and the template RNA was
then degraded upon incubation with 5 units of RNaseH,
for 30 min at 37°C.
Quantitative Real Ttime PCR (qRT-PCR)
The experiments were carried out according to the
MIQE guidelines [59]. The first step for the primer se-
lections was to select from already published data a set
of genes of interest differentially regulated during osteo-
genesis [22,60]. The primer sequences were then se-
lected from a validated bank of oligos previously tested
and approved for qRT-PCR, the PrimerBank [61]. The
primer concentration was then optimized for each gene
using a cDNA pool from different periods of time of treat-
ment with BMP2, adopting the lowest primer concentra-
tion for each condition that did not interfere with the
amplification curve inclination, in order to avoid non-
specific results derived from primer dimers. The qRT-PCR
reaction was carried out using 6 μl the SYBR® Green Dye
(Life Technologies, Carlsbad, USA), 3 μl of 30 times di-
luted cDNA and 3 μl of a mix containing both the forward
and the reverse primers (Table 3), and incubated under
the following conditions: 2 min at 50°C, 10 min at 95°C,
followed by 40 cycles of 15 seconds at 95°C and 60°C for
1 min. The data were collected and analyzed using the
7300 System Software (Life Technologies, Carlsbad, USA).
The quality control of each reaction was achieved through
a cycle of dissociation, in order to exclude possible cross-
contaminations or the presence of dimers. To confirm the
differential expression for each gene, the GeneAmp 5700
software was used, and the threshold was set to 0.1. The
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data was exported and interpreted using the qBASEPLUS2
(Biogazelle, Zwijnaarde, Belgium). The first step was to
use the Genorm [62] tool, a very popular algorithm that
finds the stablest reference (housekeeping) genes from a
set of tested candidate reference genes in a given experi-
mental condition, in this case, GAPDH, HMBS and
HPRT. From this, a gene expression normalization factor
was calculated for each sample, based on the geometric
mean of a user-defined number of the reference genes.
After analysis, the data was exported and the graphic pic-
tures and statistical analysis were performed using the
GraphPad Prism 5 software (GraphPad Software, La Jolla,
USA). The data presented in this work are representative
of 3 independent experiments, performed in duplicates,
and were analised through a one-way Anova followed by a
post-test of Tukey with p<0.005.
Additional files
Additional file 1: Phosphorylated peptides found in MS experiments.
Acession number, delta score, retention area (for light medium and
heavy labeled peptides) of phosphorylated peptides.
Additional file 2: Phosphorylated proteins found and relative ratio
variation for different timepoints of BMP2-induction and calculated
p-value for all peptides corresponding to a specific protein. For a
given accession number corresponding to a protein, a subset of peptides
were found in MS experiments, and the ratio between each timepoint
was calculated using StatQuant software according to the area of
extracted chromatogram. Statistical analysis was calculated for a
population of peptides corresponding to a same protein accession.
Additional file 3: Phosphorylated sites found in peptides according
to MS experiments and kinase phosphorylation analysis using
NetworKIN 2.0 Beta (http://www.networkin.info/version_2_0/). To
investigate which kinases could be involved in the phosphorylation of
peptides found in MS experiments, NetworKIN 2.0 Beta kinase databank
was used to match phoshorylated serine, threonine and tyrosine in
peptides found to be phoshorylated, according to prior experiments in
literature for a given kinase based on PhosphoELM (http://phospho.elm.
eu.org/) and on Phosphosite (http://www.phosphosite.org).
Additional file 4: Network of proteins which were found to interact
with phosphorylated proteins found. The list of phosphoproteins
found were subjected to Ingenuity Pathway Analysis (IPA) to investigate
probable protein interactions for each cellular compartment. Proteins
described to be transcription factors were selected to investigate the
activation of osteoblast related genes by quantitative real-time PCR.
Additional file 5: Predicted network of interaction for phosphoproteins
found using Ingenuity Pathway Analysis. Ingenuity Pathway Analysis
was used to identify the network of proteins which could interact with
the phosphoproteins identified. Dashed arrows represent the predicted
interactions and the full arrows represent a confirmed interaction. Proteins
were separated by cell compartment and proteins known to be
transcription factors were selected to further analysis to investigate possible
activators of osteoblast differentiation by real-time quantitative PCR.
Additional file 6: Motifs and Pre-selected genes used in RT-PCR
experiments. The motifs listed were used to search for correspondents
in the promoter region of the pre-selected genes. Those which displayed
at least one match matches for the sequences (SP1, c-Myc e NF-ƙB) were
selected for the qRT-PCR analysis.
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